 
                    
                GC CELL CORPORATION
Biotech firm offering cell/gene therapy CDMO services and developing immune cell cancer therapies.
144510 | KO
Overview
Corporate Details
- ISIN(s):
- KR7144510005
- LEI:
- Country:
- South Korea
- Address:
- 경기도 용인시 기흥구 이현로30번길 107, 용인시
- Website:
- http://gccell.com/en/main.do
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
GC Cell is a biotechnology company specializing in cell therapy innovation, offering a fully-integrated value chain from research to commercialization. The company provides comprehensive solutions tailored to its partners, including end-to-end Contract Development and Manufacturing Organization (CDMO) services for cell and gene therapies, specialized bio-logistics, and cell banking. In addition to its service offerings, GC Cell develops proprietary immune cell therapies, with a research focus on NK and T cells. Its flagship product, Immuncell-LC, is an approved adjuvant therapy for patients with hepatocellular carcinoma following tumor removal. The company's mission is to accelerate the development of novel cell and gene therapies to improve clinical outcomes for patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 | Interim Report 반기보고서 (2025.06) | Korean | 3.0 MB | ||
| 2025-08-01 00:00 | Earnings Release 연결재무제표기준영업(잠정)실적(공정공시)               | Korean | 15.5 KB | ||
| 2025-05-15 00:00 | Quarterly Report 분기보고서 (2025.03) | Korean | 1.8 MB | ||
| 2025-05-12 00:00 | Major Shareholding Notification 임원ㆍ주요주주특정증권등소유상황보고서 | Korean | 25.0 KB | ||
| 2025-04-30 00:00 | Earnings Release 연결재무제표기준영업(잠정)실적(공정공시)               | Korean | 15.5 KB | ||
| 2025-04-30 00:00 | Regulatory News Service 소속부변경               | Korean | 3.6 KB | ||
| 2025-04-23 00:00 | Major Shareholding Notification 임원ㆍ주요주주특정증권등소유상황보고서 | Korean | 24.1 KB | ||
| 2025-04-23 00:00 | Major Shareholding Notification 임원ㆍ주요주주특정증권등소유상황보고서 | Korean | 24.0 KB | ||
| 2025-04-23 00:00 | Major Shareholding Notification 임원ㆍ주요주주특정증권등소유상황보고서 | Korean | 24.0 KB | ||
| 2025-04-23 00:00 | Major Shareholding Notification 임원ㆍ주요주주특정증권등소유상황보고서 | Korean | 24.0 KB | ||
| 2025-04-23 00:00 | Major Shareholding Notification 임원ㆍ주요주주특정증권등소유상황보고서 | Korean | 24.0 KB | ||
| 2025-04-23 00:00 | Major Shareholding Notification 임원ㆍ주요주주특정증권등소유상황보고서 | Korean | 24.1 KB | ||
| 2025-03-25 00:00 | Board/Management Information 대표이사변경               | Korean | 10.6 KB | ||
| 2025-03-25 00:00 | Post-Annual General Meeting Information 정기주주총회결과               | Korean | 21.1 KB | ||
| 2025-03-25 00:00 | Board/Management Information 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | Korean | 12.7 KB | 
Automate Your Workflow. Get a real-time feed of all GC CELL CORPORATION filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GC CELL CORPORATION
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GC CELL CORPORATION via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value | 
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
 
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                    